This site is intended for healthcare professionals

Biologic efficacy for complications associated with moderate-to-severe psoriasis

Read time: 4 mins
Last updated:13th Feb 2020
Published:13th Feb 2020
Author: Georga Cottle
Source: Medthority
This is the final part of a three-part series on treatments for different patient groups within moderate-to-severe psoriasis. In part 2, we discussed treatments that may be suitable for young women who are of childbearing age. Here we delve into the efficacy of TNF-α treatments in patients who present with more than one feature of psoriasis disease (for example, psoriatic arthritis and nail psoriasis) and for those who have failed on prior biologic treatment.
Register free for full access to